🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the makers of Tylenol, alleging the companies hid safety concerns that the pain reliever presented to children's neurological development.

The lawsuit arrives four weeks after Former President Trump promoted an unsubstantiated connection between using acetaminophen - alternatively called paracetamol - while pregnant and autism in young ones.

Paxton is suing the pharmaceutical giant, which previously sold the drug, the exclusive pain medication suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "betrayed America by gaining financially from discomfort and marketing drugs without regard for the potential hazards."

The company states there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These corporations deceived for years, deliberately risking millions to boost earnings," Paxton, a Republican, declared.

The manufacturer stated officially that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the welfare of American women and children."

On its official site, Kenvue also said it had "consistently assessed the relevant science and there is insufficient valid information that indicates a established connection between taking paracetamol and autism spectrum disorder."

Associations acting on behalf of doctors and healthcare providers agree.

ACOG has stated paracetamol - the main ingredient in acetaminophen - is among limited choices for expectant mothers to treat discomfort and fever, which can create major wellness concerns if ignored.

"In multiple decades of investigation on the utilization of paracetamol in gestation, not a single reputable study has successfully concluded that the usage of acetaminophen in any trimester of gestation causes neurodevelopmental disorders in young ones," the association stated.

This legal action cites latest statements from the former administration in claiming the drug is allegedly unsafe.

In recent weeks, Trump generated worry from health experts when he told expectant mothers to "fight like hell" not to take acetaminophen when unwell.

The US Food and Drug Administration then published an announcement that medical professionals should contemplate reducing the use of acetaminophen, while also stating that "a proven link" between the drug and autism spectrum disorder in young ones has remains unverified.

The Health Department head Kennedy, who oversees the FDA, had pledged in April to undertake "extensive scientific investigation" that would determine the source of autism spectrum disorder in a matter of months.

But authorities cautioned that finding a unique factor of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of genetic and external influences - would not be simple.

Autism spectrum disorder is a type of lifelong neurodivergence and condition that influences how persons encounter and interact with the world, and is identified using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is seeking the Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the research" around paracetamol and autism.

The case attempts to require the companies "remove any commercial messaging" that asserts acetaminophen is secure for expectant mothers.

The Texas lawsuit mirrors the complaints of a collection of parents of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of Tylenol in 2022.

A federal judge dismissed the legal action, saying investigations from the plaintiffs' authorities was inconclusive.